33.3 F
Cambridge
Monday, January 27, 2025
- Advertisement -

CATEGORY

Science & Technology

Exiting the Holocene: Can Geoengineering Give Humanity a Lifeline to Fix the Climate Crisis?

In a world failing to decarbonize quickly enough, solar geoengineering has the potential to buy humanity time before feeling the worst effects of global warming. The complex nature of geopolitics alongside the potential consequences of solar geoengineering makes for a difficult political battlefield.

The Future of Soda, the Future of Health

Before Poppi, “healthy soda” was an oxymoron. Now, it is commonplace.

Shaping Robust AI Regulation: Lessons from India’s ‘Deepfake’ Election

When coming up with a plan for AI governance in India, a balance between regulation and innovation is essential.

Marching-In on Medication Pricing: Federal Attempts to Reduce Drug Costs

Despite recent patent challenges and modifications to the extent of march-in rights, universally accessible medical treatments are still a far-fetched fantasy.

The TikTok Playbook: PR Tips for the Democratic Nominee

TikTok’s mainly-Gen Z user base and its power to shape candidates’ public personas makes it a crucial battleground in the 2024 U.S. election, which is all about qualitative judgments.

Incentives First: A Critique of Current AI Governance Models

Last December, the Federal Trade Commission settled with Rite Aid after alleging that the company had failed to take the most basic precautions against...

AI: “Asian Intelligence”

To deconstruct the prejudice against Asians as robotic, all communities must challenge the internal and external prejudices that reduce Asians to a monolith of math-oriented, unfeeling workers.

Why the Google Antitrust Trial is a Win for All Consumers

When the U.S. Department of Justice filed an antitrust lawsuit against Alphabet, Google’s parent company, it is easy to understand how most people’s instinctive reaction was in support of the $1.7 trillion company. However, if the judge, Amit P. Mehta, does, in fact, rule against Google, it will be a win for all consumers worldwide.

We Must Increase Funding on Women’s Health Research

Studies have shown that diseases that primarily impact men receive more funding than diseases that primarily impact women nearly three-quarters of the time.

Cost Plus Drugs: An Altruistic Capitalist Venture

On the national stage where altruism towards the consumer is scarce, a new pharmaceutical company is attempting to curtail corporate greed by reducing drug costs, making medicine more accessible.